Cargando…
Immunomodulation by an Omega-6 Fatty Acid Reduced Mixed Lipid Emulsion in Murine Acute Respiratory Distress Syndrome
Background: Acute respiratory distress syndrome (ARDS) is associated with both high morbidity and mortality in intensive care units worldwide. Patients with ARDS often require parenteral nutrition with lipid emulsions as essential components. In the present study, we assessed the immunomodulatory an...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408915/ https://www.ncbi.nlm.nih.gov/pubmed/32610690 http://dx.doi.org/10.3390/jcm9072048 |
_version_ | 1783567942815842304 |
---|---|
author | Hecker, Matthias Rose, Matthias Hecker, Andreas Dietrich, Hartmut Schaefer, Martina B. Sommer, Natascha Seeger, Werner Mayer, Konstantin |
author_facet | Hecker, Matthias Rose, Matthias Hecker, Andreas Dietrich, Hartmut Schaefer, Martina B. Sommer, Natascha Seeger, Werner Mayer, Konstantin |
author_sort | Hecker, Matthias |
collection | PubMed |
description | Background: Acute respiratory distress syndrome (ARDS) is associated with both high morbidity and mortality in intensive care units worldwide. Patients with ARDS often require parenteral nutrition with lipid emulsions as essential components. In the present study, we assessed the immunomodulatory and apoptotic effects of a modern, n-6-reduced lipid emulsion mixture in murine ARDS. Methods: Mice received an infusion of either normal saline solution, pure long-chain triglyceride (LCT) emulsion, or SMOF (soybean oil, medium-chain triglycerides, olive oil, and fish oil) before a lipopolysaccharide (LPS) challenge. Mice were sacrificed at different time points (0, 24, or 72 h) after ARDS induction, and an analysis of inflammatory cytokines, protein concentrations, and the cellular composition of the alveolar and interstitial compartments was performed with special focus on alveolar apoptosis and necrosis. Results: Mice infused with SMOF showed decreased leukocyte invasion, protein leakage, myeloperoxidase activity, and cytokine production in alveolar spaces after LPS challenge compared to animals that received LCT. There were fewer cells in the lung interstitium of the SMOF group compared to the LCT group. Both lipid emulsions exerted pro-apoptotic and pro-necrotic properties on alveolar immune cells, with significantly increased necrosis in mice infused with LCT compared to SMOF. Conclusion: SMOF has both anti-inflammatory and pro-resolving influences in murine ARDS. Partial replacement of n-6 fatty acids with n-3/n-9 fatty acids may therefore benefit critically ill patients at risk for ARDS who require parenteral nutrition. |
format | Online Article Text |
id | pubmed-7408915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74089152020-08-13 Immunomodulation by an Omega-6 Fatty Acid Reduced Mixed Lipid Emulsion in Murine Acute Respiratory Distress Syndrome Hecker, Matthias Rose, Matthias Hecker, Andreas Dietrich, Hartmut Schaefer, Martina B. Sommer, Natascha Seeger, Werner Mayer, Konstantin J Clin Med Article Background: Acute respiratory distress syndrome (ARDS) is associated with both high morbidity and mortality in intensive care units worldwide. Patients with ARDS often require parenteral nutrition with lipid emulsions as essential components. In the present study, we assessed the immunomodulatory and apoptotic effects of a modern, n-6-reduced lipid emulsion mixture in murine ARDS. Methods: Mice received an infusion of either normal saline solution, pure long-chain triglyceride (LCT) emulsion, or SMOF (soybean oil, medium-chain triglycerides, olive oil, and fish oil) before a lipopolysaccharide (LPS) challenge. Mice were sacrificed at different time points (0, 24, or 72 h) after ARDS induction, and an analysis of inflammatory cytokines, protein concentrations, and the cellular composition of the alveolar and interstitial compartments was performed with special focus on alveolar apoptosis and necrosis. Results: Mice infused with SMOF showed decreased leukocyte invasion, protein leakage, myeloperoxidase activity, and cytokine production in alveolar spaces after LPS challenge compared to animals that received LCT. There were fewer cells in the lung interstitium of the SMOF group compared to the LCT group. Both lipid emulsions exerted pro-apoptotic and pro-necrotic properties on alveolar immune cells, with significantly increased necrosis in mice infused with LCT compared to SMOF. Conclusion: SMOF has both anti-inflammatory and pro-resolving influences in murine ARDS. Partial replacement of n-6 fatty acids with n-3/n-9 fatty acids may therefore benefit critically ill patients at risk for ARDS who require parenteral nutrition. MDPI 2020-06-29 /pmc/articles/PMC7408915/ /pubmed/32610690 http://dx.doi.org/10.3390/jcm9072048 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hecker, Matthias Rose, Matthias Hecker, Andreas Dietrich, Hartmut Schaefer, Martina B. Sommer, Natascha Seeger, Werner Mayer, Konstantin Immunomodulation by an Omega-6 Fatty Acid Reduced Mixed Lipid Emulsion in Murine Acute Respiratory Distress Syndrome |
title | Immunomodulation by an Omega-6 Fatty Acid Reduced Mixed Lipid Emulsion in Murine Acute Respiratory Distress Syndrome |
title_full | Immunomodulation by an Omega-6 Fatty Acid Reduced Mixed Lipid Emulsion in Murine Acute Respiratory Distress Syndrome |
title_fullStr | Immunomodulation by an Omega-6 Fatty Acid Reduced Mixed Lipid Emulsion in Murine Acute Respiratory Distress Syndrome |
title_full_unstemmed | Immunomodulation by an Omega-6 Fatty Acid Reduced Mixed Lipid Emulsion in Murine Acute Respiratory Distress Syndrome |
title_short | Immunomodulation by an Omega-6 Fatty Acid Reduced Mixed Lipid Emulsion in Murine Acute Respiratory Distress Syndrome |
title_sort | immunomodulation by an omega-6 fatty acid reduced mixed lipid emulsion in murine acute respiratory distress syndrome |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408915/ https://www.ncbi.nlm.nih.gov/pubmed/32610690 http://dx.doi.org/10.3390/jcm9072048 |
work_keys_str_mv | AT heckermatthias immunomodulationbyanomega6fattyacidreducedmixedlipidemulsioninmurineacuterespiratorydistresssyndrome AT rosematthias immunomodulationbyanomega6fattyacidreducedmixedlipidemulsioninmurineacuterespiratorydistresssyndrome AT heckerandreas immunomodulationbyanomega6fattyacidreducedmixedlipidemulsioninmurineacuterespiratorydistresssyndrome AT dietrichhartmut immunomodulationbyanomega6fattyacidreducedmixedlipidemulsioninmurineacuterespiratorydistresssyndrome AT schaefermartinab immunomodulationbyanomega6fattyacidreducedmixedlipidemulsioninmurineacuterespiratorydistresssyndrome AT sommernatascha immunomodulationbyanomega6fattyacidreducedmixedlipidemulsioninmurineacuterespiratorydistresssyndrome AT seegerwerner immunomodulationbyanomega6fattyacidreducedmixedlipidemulsioninmurineacuterespiratorydistresssyndrome AT mayerkonstantin immunomodulationbyanomega6fattyacidreducedmixedlipidemulsioninmurineacuterespiratorydistresssyndrome |